Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 1
1979 1
1980 1
1984 1
1985 1
1986 1
1987 2
1989 2
1990 1
1993 6
1994 5
1995 2
1996 3
1997 2
1998 4
1999 4
2000 5
2001 8
2002 3
2003 3
2004 14
2005 12
2006 16
2007 11
2008 22
2009 21
2010 24
2011 31
2012 24
2013 36
2014 33
2015 42
2016 43
2017 53
2018 58
2019 52
2020 57
2021 76
2022 39
Text availability
Article attribute
Article type
Publication date

Search Results

613 results
Results by year
Filters applied: . Clear all
Page 1
Showing results for daily rocha
Search for Daisy Rocha instead (1 results)
Diaphragmatic mobility: relationship with lung function, respiratory muscle strength, dyspnea, and physical activity in daily life in patients with COPD.
Rocha FR, Brüggemann AK, Francisco DS, Medeiros CS, Rosal D, Paulin E. Rocha FR, et al. J Bras Pneumol. 2017 Jan-Feb;43(1):32-37. doi: 10.1590/S1806-37562016000000097. J Bras Pneumol. 2017. PMID: 28380186 Free PMC article.
OBJECTIVE: To evaluate diaphragmatic mobility in relation to lung function, respiratory muscle strength, dyspnea, and physical activity in daily life (PADL) in patients with COPD. METHODS: We included 25 patients with COPD, classified according to the Global Initiative for …
OBJECTIVE: To evaluate diaphragmatic mobility in relation to lung function, respiratory muscle strength, dyspnea, and physical activity in …
COVID-19 epidemic in Brazil: Where are we at?
Lobo AP, Cardoso-Dos-Santos AC, Rocha MS, Pinheiro RS, Bremm JM, Macário EM, Oliveira WK, França GVA. Lobo AP, et al. Int J Infect Dis. 2020 Aug;97:382-385. doi: 10.1016/j.ijid.2020.06.044. Epub 2020 Jun 16. Int J Infect Dis. 2020. PMID: 32561425 Free PMC article.
In the last segment, from the 31(st) to the 63(rd) day, Brazil presented a daily percentage change (DPC) of 7.3% (95%CI= 7.2;7.5). For the country the average daily percentage change (ADPC) was 14.2% (95%CI: 13.8;14.5). ...
In the last segment, from the 31(st) to the 63(rd) day, Brazil presented a daily percentage change (DPC) of 7.3% (95%CI= 7.2;7.5). Fo …
Initiation of Angiotensin-Neprilysin Inhibition After Acute Decompensated Heart Failure: Secondary Analysis of the Open-label Extension of the PIONEER-HF Trial.
DeVore AD, Braunwald E, Morrow DA, Duffy CI, Ambrosy AP, Chakraborty H, McCague K, Rocha R, Velazquez EJ; PIONEER-HF Investigators. DeVore AD, et al. JAMA Cardiol. 2020 Feb 1;5(2):202-207. doi: 10.1001/jamacardio.2019.4665. JAMA Cardiol. 2020. PMID: 31825471 Free PMC article. Clinical Trial.
INTERVENTIONS: Sacubitril/valsartan titrated to 97/103 mg twice daily. DESIGN, SETTING, AND PARTICIPANTS: The PIONEER-HF trial was a multicenter, randomized, double-blind, active-controlled trial conducted at 129 US sites between May 2016 and May 2018 that compared the in- …
INTERVENTIONS: Sacubitril/valsartan titrated to 97/103 mg twice daily. DESIGN, SETTING, AND PARTICIPANTS: The PIONEER-HF trial was a …
Effect of Sacubitril-Valsartan vs Enalapril on Aortic Stiffness in Patients With Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.
Desai AS, Solomon SD, Shah AM, Claggett BL, Fang JC, Izzo J, McCague K, Abbas CA, Rocha R, Mitchell GF; EVALUATE-HF Investigators. Desai AS, et al. JAMA. 2019 Sep 17;322(11):1077-1084. doi: 10.1001/jama.2019.12843. JAMA. 2019. PMID: 31475296 Free PMC article.
INTERVENTIONS: Randomization (1:1) to sacubitril-valsartan (n = 231; target dosage, 97/103 mg twice daily) vs enalapril (n = 233; target dosage, 10 mg twice daily) for 12 weeks. ...
INTERVENTIONS: Randomization (1:1) to sacubitril-valsartan (n = 231; target dosage, 97/103 mg twice daily) vs enalapril (n = 233; tar …
Persistent Symptoms and Disability After COVID-19 Hospitalization: Data From a Comprehensive Telerehabilitation Program.
Leite VF, Rampim DB, Jorge VC, de Lima MDCC, Cezarino LG, da Rocha CN, Esper RB; Prevent Senior COVID-19 Rehabilitation Study. Leite VF, et al. Arch Phys Med Rehabil. 2021 Jul;102(7):1308-1316. doi: 10.1016/j.apmr.2021.03.001. Epub 2021 Mar 10. Arch Phys Med Rehabil. 2021. PMID: 33711279 Free PMC article.
INTERVENTIONS: Not applicable. MAIN OUTCOME MEASURES: Dependence for basic activities of daily living (ADL) and instrumental activities of daily living (IADL) using the Barthel Index and Lawton's Scale. ...
INTERVENTIONS: Not applicable. MAIN OUTCOME MEASURES: Dependence for basic activities of daily living (ADL) and instrumental activiti …
Metals in Brazilian family farming grapes and estimated daily intake.
Hoeltgebaum D, Pedron T, Paniz FP, Souza AA, Romoli JCZ, Lini RS, Pante GC, Rocha GHO, Batista BL, Machinski Junior M. Hoeltgebaum D, et al. Food Addit Contam Part B Surveill. 2021 Sep;14(3):236-243. doi: 10.1080/19393210.2021.1933612. Epub 2021 Jun 18. Food Addit Contam Part B Surveill. 2021. PMID: 34142923
The aim of this study was to determine concentrations of metals in peel, pulp, and seeds of grapes obtained from family farms in Brazil, compare them to the maximum threshold levels and to evaluate the risk by estimating the daily intake (EDI). Grape samples were collected …
The aim of this study was to determine concentrations of metals in peel, pulp, and seeds of grapes obtained from family farms in Brazil, com …
Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthroplasty.
Eriksson BI, Borris LC, Friedman RJ, Haas S, Huisman MV, Kakkar AK, Bandel TJ, Beckmann H, Muehlhofer E, Misselwitz F, Geerts W; RECORD1 Study Group. Eriksson BI, et al. N Engl J Med. 2008 Jun 26;358(26):2765-75. doi: 10.1056/NEJMoa0800374. N Engl J Med. 2008. PMID: 18579811 Free article. Clinical Trial.
METHODS: In this randomized, double-blind study, we assigned 4541 patients to receive either 10 mg of oral rivaroxaban once daily, beginning after surgery, or 40 mg of enoxaparin subcutaneously once daily, beginning the evening before surgery, plus a placebo tablet …
METHODS: In this randomized, double-blind study, we assigned 4541 patients to receive either 10 mg of oral rivaroxaban once daily, be …
Rationale and design of the comParIson Of sacubitril/valsartaN versus Enalapril on Effect on nt-pRo-bnp in patients stabilized from an acute Heart Failure episode (PIONEER-HF) trial.
Velazquez EJ, Morrow DA, DeVore AD, Ambrosy AP, Duffy CI, McCague K, Hernandez AF, Rocha RA, Braunwald E. Velazquez EJ, et al. Am Heart J. 2018 Apr;198:145-151. doi: 10.1016/j.ahj.2018.01.004. Epub 2018 Jan 10. Am Heart J. 2018. PMID: 29653636 Free article. Clinical Trial.
Patients are randomly assigned 1:1 to in-hospital initiation of sacubitril/valsartan titrated to 97/103 mg by mouth twice daily versus enalapril titrated to 10 mg by mouth twice daily for 8 weeks. ...
Patients are randomly assigned 1:1 to in-hospital initiation of sacubitril/valsartan titrated to 97/103 mg by mouth twice daily versu …
Effects of zinc supplementation on fatigue and quality of life in patients with colorectal cancer.
Ribeiro SMF, Braga CBM, Peria FM, Martinez EZ, Rocha JJRD, Cunha SFC. Ribeiro SMF, et al. Einstein (Sao Paulo). 2017 Jan-Mar;15(1):24-28. doi: 10.1590/S1679-45082017AO3830. Einstein (Sao Paulo). 2017. PMID: 28444084 Free PMC article. Clinical Trial.
The study patients received zinc capsules 35mg (Zinc Group, n=10) or placebo (Placebo Group, n=14) orally, twice daily (70mg/day), for 16 weeks, from the immediate postoperative period to the fourth chemotherapy cycle. ...
The study patients received zinc capsules 35mg (Zinc Group, n=10) or placebo (Placebo Group, n=14) orally, twice daily (70mg/day), fo …
Daily corticosterone rhythm modulates pineal function through NFκB-related gene transcriptional program.
da Silveira Cruz-Machado S, Tamura EK, Carvalho-Sousa CE, Rocha VA, Pinato L, Fernandes PAC, Markus RP. da Silveira Cruz-Machado S, et al. Sci Rep. 2017 May 18;7(1):2091. doi: 10.1038/s41598-017-02286-y. Sci Rep. 2017. PMID: 28522814 Free PMC article.
Melatonin and glucocorticoids are key hormones in determining daily rhythmicity and modulating defense responses. In nocturnal animals, corticosterone peaks at light/dark transition,while melatonin peaks at the middle of the night in both nocturnal and diurnal animals. ...
Melatonin and glucocorticoids are key hormones in determining daily rhythmicity and modulating defense responses. In nocturnal animal …
613 results